PSNC: Contractors need ‘assurances’ on impact of HRT prescription changes

The government’s move to implement longer prescription cycles on hormone replacement therapy (HRT) could have “complex consequences” for pharmacy contractors, Pharmaceutical Services Negotiating Committee (PSNC) director of pharmacy funding Mike Dent has said.